Investors who are intrigued by the promise of new healthcare technology to fight cancer will probably want to look at Genomic Health (NASDAQ:GHDX) stock. The provider of genomic-based diagnostic tests has set itself apart from other genomic companies with its Oncotype product line.
Is Genomic Health the kind of stock that could generate huge returns over the long run?
